Robert Funk, M.D., has returned from Dallas, Texas, where he learned the placement of the new dorsal root ganglia (DRG) spinal cord stimulation leads

funkSpinal cord stimulation can be an effective treatment for chronic neck and back pain when surgery and non-surgical therapies are not an option.

But treating some patients can still be challenging. This year, the Federal Drug Administration (FDA) gave the green light to Dorsal Root Ganglion (DRG) Stimulation, a new treatment for complex cases.

Robert Funk, M.D., has returned from Dallas, Texas, where he learned the placement of the new dorsal root ganglia (DRG) spinal cord stimulation leads. This system has been used in Europe for several years and can provide significantly improved pain relief for some patients as compared to traditional spinal cord stimulation. With the FDA clearance of this device there are strict training protocols that physicians must participate in prior to using the technology.

DRG stimulation is an exciting technology that can provide significant relief in the right patients.

With this training, Indiana Spine Group physicians continue to be on the cutting edge in order to provide our patients with the newest and most effective treatments for spine disorders.

February 2016 Press Release:

http://media.sjm.com/newsroom/news-releases/news-releases-details/2016/St-Jude-Medical-Announces-FDA-Approval-of-a-New-Treatment-Therapy-for-Patients-Suffering-From-Chronic-Intractable-Pain/default.aspx